“Tirzepatide Protects the Heart from Doxorubicin-Induced Cardiotoxicity via Modulating ER Stress”. MSW Management Journal, vol. 36, no. 1, Mar. 2026, pp. 3056-61, https://doi.org/10.7492/ma41ae60.